Literature DB >> 22130541

The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release.

Jason Hammonds1, Lingmei Ding, Hin Chu, Ken Geller, Andrew Robbins, Jaang-Jiun Wang, Hong Yi, Paul Spearman.   

Abstract

Tetherin/BST-2 forms a proteinaceous tether that restricts the release of a number of enveloped viruses following viral budding. Tetherin is an unusual membrane glycoprotein with two membrane anchors and an extended coiled-coil ectodomain. The ectodomain itself forms an imperfect coil that may undergo conformational shifts to accommodate membrane dynamics during the budding process. The coiled-coil ectodomain is required for restriction, but precisely how it contributes to the restriction of particle release remains under investigation. In this study, mutagenesis of the ectodomain was used to further define the role of the coiled-coil ectodomain in restriction. Scanning mutagenesis throughout much of the ectodomain failed to disrupt the ability of tetherin to restrict HIV particle release, indicating a high degree of plasticity. Targeted N- and C-terminal substitutions disrupting the coiled coil led to both a loss of restriction and an alteration of subcellular distribution. Two ectodomain mutants deficient in restriction were endocytosed inefficiently, and the levels of these mutants on the cell surface were significantly enhanced. An ectodomain mutant with four targeted serine substitutions (4S) failed to cluster in membrane microdomains, was deficient in restriction of particle release, and exhibited an increase in lateral mobility on the membrane. These results suggest that the tetherin ectodomain contributes to microdomain localization and to constrained lateral mobility. We propose that focal clustering of tetherin via ectodomain interactions plays a role in restriction of particle release.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130541      PMCID: PMC3302402          DOI: 10.1128/JVI.05906-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

2.  Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Kasinath Viswanathan; Janet L Douglas; Jennie Hines; Jean Gustin; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

3.  The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

Authors:  Liwei Rong; Jianyong Zhang; Jennifer Lu; Qinghua Pan; René-Pierre Lorgeoux; Claudette Aloysius; Fei Guo; Shan-Lu Liu; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

4.  Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.

Authors:  Anna Le Tortorec; Stuart J D Neil
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

5.  Construction of ICAM-1-GFP and its binding with Molt-4 cells.

Authors:  Wei-Hua Chen; Wan-Ming DA; Chun-Ji Gao
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2009-06

6.  A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells.

Authors:  Ruth Rollason; Viktor Korolchuk; Clare Hamilton; Mark Jepson; George Banting
Journal:  J Cell Biol       Date:  2009-03-09       Impact factor: 10.539

7.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

8.  Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses.

Authors:  Toshie Sakuma; Akira Sakurai; Jiro Yasuda
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

9.  Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

Authors:  Fengwen Zhang; Sam J Wilson; Wilmina C Landford; Beatriz Virgen; Devon Gregory; Marc C Johnson; Jan Munch; Frank Kirchhoff; Paul D Bieniasz; Theodora Hatziioannou
Journal:  Cell Host Microbe       Date:  2009-06-04       Impact factor: 21.023

10.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

View more
  25 in total

1.  Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivo.

Authors:  Victor H Leyva-Grado; Rong Hai; Fiona Fernandes; Alan Belicha-Villanueva; Carol Carter; Mark A Yondola
Journal:  J Mol Biol       Date:  2013-12-29       Impact factor: 5.469

Review 2.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

3.  HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Authors:  Vijaya Madhavi; Bruce D Wines; Janaki Amin; Sean Emery; Ester Lopez; Anthony Kelleher; Rob J Center; P Mark Hogarth; Amy W Chung; Stephen J Kent; Ivan Stratov
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

4.  Native immunogold labeling of cell surface proteins and viral glycoproteins for cryo-electron microscopy and cryo-electron tomography applications.

Authors:  Hong Yi; Joshua D Strauss; Zunlong Ke; Eric Alonas; Rebecca S Dillard; Cheri M Hampton; Kristen M Lamb; Jason E Hammonds; Philip J Santangelo; Paul W Spearman; Elizabeth R Wright
Journal:  J Histochem Cytochem       Date:  2015-06-11       Impact factor: 2.479

5.  Mechanism of Tetherin Inhibition of Alphavirus Release.

Authors:  Judy J Wan; Yaw Shin Ooi; Margaret Kielian
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

6.  Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are governed by structurally-distinct BST2 determinants.

Authors:  Mariana G Bego; Nolwenn Miguet; Alexandre Laliberté; Nicolas Aschman; Francine Gerard; Angelique A Merakos; Winfried Weissenhorn; Éric A Cohen
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

Review 7.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

8.  Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.

Authors:  Sarah Welbourn; Sandra Kao; Kelly E Du Pont; Amy J Andrew; Christopher E Berndsen; Klaus Strebel
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

9.  The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release.

Authors:  Amy J Andrew; Christopher E Berndsen; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

10.  Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites.

Authors:  Jonathan R Grover; G Nicholas Llewellyn; Ferri Soheilian; Kunio Nagashima; Sarah L Veatch; Akira Ono
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.